Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (50%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BONAPARTE, AMY C | 1 | 79.4% | +23.1% |
| BRAUN, MADELINE E | 1 | 67.9% | +25.4% |
| POHNERT, STEVEN C | 1 | 12.2% | +18.7% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.6% | +21.2% |
| WILSON, JERICA KATLYNN | 1 | 61.5% | +38.7% |
| GUSSOW, ANNE | 1 | 58.0% | +42.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18349256 | TREATMENT OF BRAIN METASTASES AND CNS METASTASES USING ILLUDINS OR HYDROXYLUREAMETHYL ACYLFULVENE | BRAUN, MADELINE E | 89d overdue |
| 17995904 | Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer | WILSON, JERICA KATLYNN | 14d |
| 17998117 | Method For Treating Pancreatic Cancer | MAHLUM, JONATHAN DAVIS | 26d |
| 17811812 | Method for Determining Sensitivity to 2,2'-Dithio-bis-Ethane Sulfonate | GUSSOW, ANNE | 77d |
| 18319919 | CANCER DRUG SENSITIVITY DETERMINING MARKERS | POHNERT, STEVEN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18349256 | TREATMENT OF BRAIN METASTASES AND CNS METASTASES USING ILLUDINS OR HYDROXYLUREAMETHYL ACYLFULVENE | BRAUN, MADELINE E | 89d overdue |
| 18238512 | ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME | BONAPARTE, AMY C | 2d overdue |
| 17995904 | Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer | WILSON, JERICA KATLYNN | 14d |
| 17998117 | Method For Treating Pancreatic Cancer | MAHLUM, JONATHAN DAVIS | 26d |
| 17811812 | Method for Determining Sensitivity to 2,2'-Dithio-bis-Ethane Sulfonate | GUSSOW, ANNE | 77d |
| 18319919 | CANCER DRUG SENSITIVITY DETERMINING MARKERS | POHNERT, STEVEN C | — |
| Art Unit | Apps |
|---|---|
| 1683 | 2 |
| 1692 | 1 |
| 1624 | 1 |
| 1625 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18238512 | ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME | BONAPARTE, AMY C | 1692 | §112 | Non-Final OA | 2d overdue | Pending | Aug 27, 2023 |
| 18349256 | TREATMENT OF BRAIN METASTASES AND CNS METASTASES USING ILLUDINS OR HYDROXYLUREAMETHYL ACYLFULVENE | BRAUN, MADELINE E | 1624 | §103§112 | Final Rejection | 89d overdue | Pending | Jul 10, 2023 |
| 18319919 | CANCER DRUG SENSITIVITY DETERMINING MARKERS | POHNERT, STEVEN C | 1683 | §101§103§112 | Non-Final OA | — | Pending | May 18, 2023 |
| 17998117 | Method For Treating Pancreatic Cancer | MAHLUM, JONATHAN DAVIS | 1625 | §101§102§103§112 | Non-Final OA | 26d | Pending | Nov 07, 2022 |
| 17995904 | Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer | WILSON, JERICA KATLYNN | 1621 | §103§112 | Final Rejection | 14d | Pending | Oct 10, 2022 |
| 17811812 | Method for Determining Sensitivity to 2,2'-Dithio-bis-Ethane Sulfonate | GUSSOW, ANNE | 1683 | §101§103§112 | Final Rejection | 77d | Pending | Jul 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial